For Immediate Release

Organization Profile: 
Contact: 

Phone: 202-588-1000

Government Should End Monopoly Control of Remdesivir

Statement of Peter Maybarduk, Director, Public Citizen’s Access to Medicines Program

WASHINGTON - A bipartisan group of 34 state attorneys general sent a letter today asking the federal government to authorize generic competition for remdesivir, in order to mitigate drug shortages and lower prices. Public Citizen found that taxpayers have invested a minimum of $70.5 million in remdesivir’s development and has contended that Gilead should price the treatment at no more than $1 per day.

Statement of Peter Maybarduk, Director, Public Citizen’s Access to Medicines Program:

SCROLL TO CONTINUE WITH CONTENT

At Stake?

An existential threat to our democracy. A global pandemic. An unprecedented economic crisis. Our journalism has never been more needed.

Can you pitch in today and help us make our Fall Campaign goal of $80,000 by November 2nd?

Please select a donation method:



Gilead’s monopoly control of remdesivir leads to shortages and rationing and keeps prices high. Taxpayers funded remdesivir’s development from the drug’s early days. Generic competition would help expand supply and ensure reasonable pricing. The federal government – we the people, that is – appears to co-own remdesivir’s core patents. Remdesivir should be in the public domain.

While remdesivir is no kind of pandemic panacea, still hospitals should be able to rely on a robust, affordable supply and make choices according to medical need.

###

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Please select a donation method:



Public Citizen is a national, nonprofit consumer advocacy organization founded in 1971 to represent consumer interests in Congress, the executive branch and the courts.

Share This Article